Combinations of regenerative medicine and Lab-on-a-chip systems: New hope to restoring the proper function of pancreatic islets in diabetes

Biosens Bioelectron. 2020 Nov 1:167:112451. doi: 10.1016/j.bios.2020.112451. Epub 2020 Jul 25.

Abstract

Cases of type 2 diabetes mellitus have significantly increased in recent years. Researchers worldwide are combining their knowledge of biology, medicine, tissue engineering, and microtechnology to develop new effective treatments. An important aspect of current research is to develop of a complete model of three-dimensional pancreatic islets to test various factors that affect disease development and evaluate new therapies and drugs. Several methods have allowed the development of three-dimensional research models. The use of Lab-on-a-chip systems with appropriate microstructure geometry is a promising solution to macroscale problems. Such a device allows the development of a complete platform reflecting conditions that prevail in the body. Organ-on-a-chip platforms are successfully used mainly in studies of lung, heart, and liver diseases. This review presents the current state of knowledge on the creation of three-dimensional pancreatic islet structures in both microscale and microfluidic systems. We highlight the most important aspects of developing the geometry of such devices. We also discuss analytical detection methods that are suitable for detecting hormones that are secreted from pancreatic islets and, in combination with appropriate Lab-on-a-chip systems, can be used as a Micro Total Analysis System (μTAS).

Keywords: Diabetes mellitus; Insulin secretion; Lab-on-a-chip; Microfluidic system; Pancreatic islet; Three-dimensional model.

Publication types

  • Review

MeSH terms

  • Biosensing Techniques*
  • Diabetes Mellitus, Type 2*
  • Humans
  • Islets of Langerhans*
  • Lab-On-A-Chip Devices
  • Regenerative Medicine